IndyGeneUS Bio Launches Africa’s First AI×Bio Factory™ Accelerating AI-Driven Drug Discovery and Gene Therapies
Summary
IndyGeneUS Bio launched Africa’s first AI×Bio Factory in South Africa with The Aurum Institute and Global Health Innovations. The platform combines clinico-genomic, clinical, pathology, imaging, and real-world evidence data to support AI-driven drug discovery, precision medicine, biomarker development, and advanced diagnostics. The company says the initiative will generate more than one million African clinico-genomic insights over time and create a major biomedical intelligence ecosystem. It also positions Oracle Cloud Infrastructure as part of the underlying stack and extends collaboration into Nigeria through an MoU with NBRDA. The launch creates a data, cloud, and analytics foundation for life sciences organizations, researchers, governments, and investors interested in African health innovation.